Chemotherapy versus best supportive care for extensive small cell lung cancer
Author:
Publisher
John Wiley & Sons, Ltd
Reference63 articles.
1. Clinical experiences with Holoxan in small cell carcinoma of the bronchus (author's transl);Kokron;Osterr Kneipp Mag,1977
2. Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell lung cancer. A clinical study;Kokron;Onkologie,1982
3. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer;Allan;Cancer Chemother Pharmacol,1984
4. A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer;Anderson;British Journal of Cancer,1993
5. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group phase III trial-08923;Ardizzoni;Journal of Clinical Oncology,2002
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan;International Journal of Molecular Sciences;2022-06-24
2. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients With Extensive-Stage Small Cell Lung Carcinoma Treated with Atezolizumab in Combination with Chemotherapy: Single Center Experience;SSRN Electronic Journal;2021
3. Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer;JAMA Network Open;2020-04-22
4. Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis;Therapeutic Advances in Medical Oncology;2020-01
5. Sequencing brain metastases and opportunities for targeted therapies;Pharmacogenomics;2017-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3